PPARA and metabolic dysfunction-associated steatotic liver disease: Peroxisome proliferator activated receptor-α (PPARα) and fatty acid transporter (CD36) participates in the NAFLD process, and CD36 also serves as an important target for PPARα according to the previous reports (Chen et al., 2019).